Medrobotics gets expanded CE mark nod for its robot-assisted surgical device

The European Union has given its CE mark approval to Medrobotics’ Flex robot-assisted surgery system, expanding the device’s indication to include colorectal procedures. 

The company, which is based in Raynham, MA, touts itself as the first in its field to offer minimally invasive and steerable robotic products for colorectal uses.

“CE Mark for colorectal procedures is significant since it expands the number of patients who can be treated with the Flex robotic system and provides a true platform technology that multiple hospital departments can use,” Samuel Straface, Medrobotics’ CEO, said in a statement. “When combined with the unrivaled mobility of the system, European otolaryngology and colorectal surgeons can now perform minimally invasive surgery through the body’s natural orifices, offering the potential for truly scarless surgeries.”

FREE DAILY NEWSLETTER

Like this story? Subscribe to FierceBiotech!

Biopharma is a fast-growing world where big ideas come along every day. Our subscribers rely on FierceBiotech as their must-read source for the latest news, analysis and data in the world of biotech and pharma R&D. Sign up today to get biotech news and updates delivered to your inbox and read on the go.

Earlier this year, the Flex system won Best-in-Show honors at the Medical Design Excellence Awards. The robot-assisted surgical platform is designed to be affordable, easy-to-use and highly mobile for hospitals and surgeons when performing minimally invasive treatments, the company said.

In November last year, Medrobotics raised $25 million just months after gaining FDA 510(k) clearance for transoral procedures.

Suggested Articles

The FDA granted an expanded indication to GT Medical’s GammaTile cancer therapy, broadening its use to newly diagnosed brain cancer patients.

A new company focusing on sperm rather than egg biology debuted with goals of increasing fertility rates and reducing pregnancy complications.

Verily has obtained a second agency green light for measuring irregular heartbeats using its prescription smartwatch.